Skip to main content

Table 3 Univariate- and multivariate analysis with respect to disease-free survival in 239 all breast cancers

From: Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer

Parameter

Univariate analysis

Multivariate analysis

Hazard ratio

95% CI

p value

Hazard ratio

95% CI

p value

  

all breast cancers (n = 239)

Age

≤56

1.434

0.808–2.574

0.218

   

Menopause

Pre

1.149

0.637–2.040

0.639

   

Tumor size (cm)

> 2

1.799

0.728–5.979

0.223

   

Lymph node status

Positive

2.494

1.143–6.550

0.020

2.826

1.281–7.474

0.008

Nuclear grade

3

1.086

0.510–2.103

0.819

   

Ki67 (%)

≤14

1.717

0.959–3.052

0.069

   

Intrinsic subtype

TNBC

1.015

0.542–1.828

0.962

   

Pathological response

non-pCR

1.965

1.050–3.948

0.034

1.693

0.861–3.514

0.129

LMR

Low

2.318

1.285–4.350

0.005

2.245

1.237–4.233

0.008

NLR

High

1.680

0.884–3.465

0.116

   
  1. TNBC triple-negative breast cancer, pCR pathological complete response, NLR neutrophil-to-lymphocyte ratio, LMR lymphocyte-to-monocyte ratio, CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us